U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07108257) titled 'Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression' on June 20.
Brief Summary: The goal of this clinical trial is to evaluate the safety and initial effectiveness of MR-guided focused ultrasound (MRgFUS) bilateral capsulotomy in patients with treatment-resistant bipolar depression (TRBD).
Study Start Date: June 25
Study Type: INTERVENTIONAL
Condition:
Treatment-Resistant Depression
Bipolar Depression
Intervention:
DEVICE: ExAblate Neuro 4000
ExAblate Neuro 4000 is an MR-guided focused ultrasound (MRgFUS) device used to perform noninvasive thermal ablation of ta...